Masimo Corporation (NASDAQ:MASI) Given Consensus Recommendation of “Hold” by Analysts

Masimo Corporation (NASDAQ:MASI) has been assigned a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a hold rating. The average 12-month price objective among brokers that have covered the stock in the last year is $180.40.

A number of equities research analysts have weighed in on MASI shares. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th.

Institutional Investors Weigh In On Masimo

Several hedge funds have recently added to or reduced their stakes in the stock. Naya Capital Management UK Ltd. purchased a new stake in shares of Masimo in the fourth quarter worth $202,984,000. AQR Capital Management LLC raised its position in shares of Masimo by 3,416.5% in the 4th quarter. AQR Capital Management LLC now owns 1,091,326 shares of the medical equipment provider’s stock worth $141,938,000 after purchasing an additional 1,060,292 shares during the last quarter. Viking Global Investors LP purchased a new position in shares of Masimo in the 2nd quarter worth about $129,096,000. Squarepoint Ops LLC raised its position in shares of Masimo by 738.8% in the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock worth $91,619,000 after purchasing an additional 546,905 shares during the last quarter. Finally, SG Americas Securities LLC boosted its stake in Masimo by 3,082.3% in the 1st quarter. SG Americas Securities LLC now owns 522,824 shares of the medical equipment provider’s stock worth $92,995,000 after purchasing an additional 506,395 shares in the last quarter. 85.96% of the stock is owned by institutional investors.

Masimo Stock Performance

Shares of NASDAQ MASI opened at $179.95 on Friday. Masimo has a 1 year low of $125.94 and a 1 year high of $179.99. The stock has a market cap of $9.42 billion, a P/E ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. The firm has a 50-day moving average of $179.15 and a 200 day moving average of $164.53. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.